查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1448495

人類微生物組市場：趨勢、預測、競爭分析 [2024-2030]

Human Microbiome Market: Trends, Forecast and Competitive Analysis [2024-2030]
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

人類微生物組市場趨勢與預測

預計到 2028 年，全球人類微生物組市場將達到約 25 億美元，2024 年至 2030 年的年複合成長率為 17.8%。該市場的主要驅動力是對人類微生物組治療的日益關注以及總體基因體學和次世代定序儀技術進步的不斷擴大。由於醫療產業的機遇，全球人類微生物組市場的未來充滿希望。

人類微生物組市場的新興趨勢

對產業動態有直接影響的新興趨勢包括使用細菌微生物組進行癌症治療以及引入下一代益生菌微生物衍生分子用於肥胖治療。

人類微生物組市場洞察

  • Lucintel 預計，由於健康問題日益嚴重、人們對營養/飲食與健康之間關係的認知不斷提高，以及益生菌市場對乳製品和其他食品的滲透率不斷提高，益生菌將成為預測期內最大的細分市場。
  • 隨著人們越來越意識到抗生素使用對自然菌叢的負面影響（例如菌叢失調），感染疾病變得越來越普遍，這凸顯了針對特定細菌的治療方法對感染疾病的需求，預計傳染病病仍將是最大的疾病類型。
  • 由於與文明病盛行率不斷上升、預防保健意識不斷增強、微生物組研究資金的可用性以及益生菌產品的接受度不斷提高，預計北美在預測期內仍將是最大的地區。由於生活方式的改變以及對人類微生物組治療方法日益濃厚的興趣，導致慢性病增加，預計亞太地區在預測期內將出現最高的成長。

常問問題

Q1.市場規模為：

答：到 2028 年，全球人類微生物組市場預計將達到 25 億美元。

Q2.市場成長預測是多少：

答：2024年至2030年，人類微生物組市場預計將以17.8%的年複合成長率成長。

Q3. 影響市場成長的關鍵促進因素是：

答：這個市場的主要驅動力是對人類微生物組治療的日益關注以及總體基因體學和次世代定序儀的技術進步。

Q4. 人類微生物組的主要應用或最終用途產業有哪些？

答：治療和診斷是人類微生物組的主要用途。

Q5.人類微生物組市場有哪些新趨勢？

答：對產業動態有直接影響的新興趨勢包括使用細菌微生物組來治療癌症以及採用下一代益生菌微生物衍生分子來治療肥胖。

Q6. 涉及人類微生物組的主要企業有哪些？

答：人類微生物組的主要企業是：

  • Enterome
  • Seres Therapeutics
  • 4D Pharma
  • DuPont
  • Vedanta Biosciences
  • Osel
  • Merck & Co.
  • Second Genome
  • Metabiomics Corporation

Q7. 人類微生物組產品領域最大的未來是什麼？

答： 食品預計益生菌在我們預測中仍將是最大的產品領域。

問題 8：未來五年，哪個地區的人類微生物組市場預計成長最大？

答：北美仍然是最大的，亞太地區預計將在未來五年內經歷最高的成長。

Q9. 可以客製化報告嗎？

答：是的，Lucintel 列出了 10% 的客製化服務，無需額外費用。

目錄

第1章執行摘要

第2章 市場背景及分類

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢和預測
  • 全球人類微生物組市場趨勢及預測
  • 按產品分類的全球人類微生物組市場
    • 益生元
    • 益生菌
    • 食品
    • 醫療食品
    • 藥品
  • 按疾病類型分類的全球人類微生物組市場
    • 傳染性的
    • 新陳代謝/內分泌
    • 癌症
    • 血
    • 神經系統
  • 按研究技術分類的全球人類微生物組市場
    • 蛋白質體學
    • 代謝體學
    • 基因組學
  • 全球人類微生物組市場（按應用）
    • 治療
    • 診斷

第4章 區域市場趨勢及預測分析

  • 全球人類微生物組市場（按地區）
  • 北美人類微生物組市場
  • 歐洲人類微生物組市場
  • 亞太人類微生物組市場
  • 其他地區的人類微生物組市場

第5章 競爭分析

  • 產品系列分析
  • 市場佔有率分析
  • 地理範圍
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球人類微生物組市場成長機會（按產品）
    • 按疾病類型分類的全球人類微生物組市場成長機會
    • 研究科技的全球人類微生物組市場成長機會
    • 全球人類微生物組市場成長機會（按應用）
    • 按地區分類的全球人類微生物組市場成長機會
  • 全球人類微生物組市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球人類微生物組市場的產能
    • 全球人類微生物組市場的合併、收購和合資企業

第7章主要企業概況

  • Enterome
  • Seres Therapeutics
  • 4D Pharma
  • DuPont
  • Vedanta Biosciences
  • Osel
  • Yakult Hoshna
  • Merck & Co
  • Second Genome
  • Metabiomics Corporation .
簡介目錄

Human Microbiome Market Trends and Forecast

The future of the global human microbiome market looks promising with opportunities in the healthcare industry. The global human microbiome market is expected to reach an estimated $2.5 billion by 2028 with a CAGR of 17.8% from 2024 to 2030.The major drivers for this market are increasing focus on human microbiome therapies and growing technological advancements in metagenomics and next-generation sequencing.

Emerging Trends in the Human Microbiome Market

Emerging trends, which have a direct impact on the dynamics of the industry, include usage of bacterial microbiome for cancer treatment and introduction of next-generation probiotic microbiota-derived molecules for treatment of obesity.

A total of 119 figures / charts and 99 tables are provided in this 209-page report to help in your business decisions. A sample figure with some insights is shown below.

Human Microbiome Market by Segment

In this market, therapeutics is the largest application market, whereas probiotics is the largest market by product type.

The study includes trends and forecast for the global human microbiome market by product, disease type, research technology, application, and region as follows:

Human Microbiome By Product [Value ($M) from 2018 to 2030]:

  • Prebiotics
  • Probiotics
  • Food
  • Medical Food
  • Drugs

Human Microbiome By Disease Type [Value ($ Million) from 2018 to 2030]:

  • Infectious
  • Metabolic/ Endocrine
  • Cancer
  • Blood
  • Neurological

Human Microbiome By Research Technology [Value ($ Million) from 2018 to 2030]:

  • Proteomics
  • Metabolomics
  • Genomics

Human Microbiome By Application [Value ($ Million) from 2018 to 2030]:

  • Therapeutics
  • Diagnostics

Human Microbiome By Region [Value ($ Million from 2018 to 2030]:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • India
  • ROW
    • Brazil

List of Human Microbiome Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies human microbiome companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the human microbiome companies profiled in this report include.

  • Enterome
  • Seres Therapeutics
  • 4D Pharma
  • DuPont
  • Vedanta Biosciences
  • Osel
  • Merck & Co.
  • Second Genome
  • Metabiomics Corporation

Human Microbiome Market Insights

  • Lucintel forecasts that probiotics will remain the largest segment over the forecast period due to increasing health concerns; growing awareness of the relationship between nutrition, diet, and health; and increasing penetration of the probiotic market in dairy and other foods.
  • Infectious disease will remain the largest disease type over the forecast period due to increasing cognizance of the negative effects of antibiotic use on the natural flora (such as disruptions), which has highlighted the need for specific bacterial-targeted therapies for infectious diseases.
  • North America will remain the largest region over the forecast period due to increasing incidence of lifestyle-related diseases, rising awareness of preventive healthcare, availability of funding for microbiome research, and growing acceptance of probiotic products. APAC is expected to witness the highest growth over the forecast period due rising chronic diseases caused by changes in lifestyle and growing interest in human microbiome treatment approaches.

Features of the Human Microbiome Market

  • Market Size Estimates: Global human microbiome market size estimation in terms of value ($M) shipment.
  • Trend and Forecast Analysis: Market trends (2018-2023) and forecast (2024-2030) by various segments.
  • Segmentation Analysis: Global human microbiome market size by product, disease type, research technology, application, and region in terms of value.
  • Regional Analysis: Global human microbiome market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different product, disease type, research technology, application, and region for the global human microbiome market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global human microbiome market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the human microbiome market size?

Answer:The global human microbiome market is expected to reach an estimated $2.5 billion by 2028.

Q2. What is the growth forecast for human microbiome market?

Answer:The human microbiome market is expected to grow at a CAGR of 17.8% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the human microbiome market?

Answer: The major drivers for this market are increasing focus on human microbiome therapies and technological advancements in metagenomics and next-generation sequencing.

Q4. What are the major applications or end use industries for human microbiome?

Answer:Therapeutics and Diagnostics are the major applications for human microbiome

Q5. What are the emerging trends in human microbiome market?

Answer:Emerging trends, which have a direct impact on the dynamics of the industry, include usage of bacterial microbiome for cancer treatment and introduction of next-generation probiotic microbiota-derived molecules for treatment of obesity.

Q6. Who are the key human microbiome companies?

Answer:Some of the key human microbiome companies are as follows:

  • Enterome
  • Seres Therapeutics
  • 4D Pharma
  • DuPont
  • Vedanta Biosciences
  • Osel
  • Merck & Co.
  • Second Genome
  • Metabiomics Corporation

Q7.Which human microbiome product segment will be the largest in future?

Answer: Lucintel forecasts that probiotics will remain the largest product segment over the forecast period due to increasing health concerns; growing awareness of the relationship between nutrition, diet, and health; and increasing penetration of the probiotic market in dairy and other foods.

Q8: In human microbiome market, which region is expected to be the largest in next 5 years?

Answer:North America will remain the largest region and Asia Pacific expected to witness the highest growth over next 5 years.

Q9. Do we receive customization in this report?

Answer:Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

  • Q.1 What are some of the most promising growth opportunities for the global human microbiome market by product (prebiotics, probiotics, food, medical food, and drugs), disease type (infectious, metabolic/endocrine, cancer, blood, and neurological), research technology (proteomics, metabolomics, and genomics), application (therapeutics and diagnostics), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2 Which segments will grow at a faster pace and why?
  • Q.3 Which region will grow at a faster pace and why?
  • Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global human microbiome market?
  • Q.5 What are the business risks and threats to the global human microbiome market?
  • Q.6 What are the emerging trends in this human microbiome market and the reasons behind them?
  • Q.7 What are some changing demands of customers in the human microbiome market?
  • Q.8 What are the new developments in the human microbiome market? Which companies are leading these developments?
  • Q.9 Who are the major players in the human microbiome market? What strategic initiatives are being implemented by key players for business growth?
  • Q.10 What are some of the competitive products and processes in the human microbiome market, and how big of a threat do they pose for loss of market share via material or product substitution?
  • Q.11 What M&A activities did take place in the last five years in the global human microbiome market?

Table of Contents

1. Executive Summary

2. Market Background and Classifications

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1: Macroeconomic Trends and Forecast
  • 3.2: Global Human Microbiome Market Trends and Forecast
  • 3.3: Global Human Microbiome Market by Product
    • 3.3.1: Prebiotics
    • 3.3.2: Probiotics
    • 3.3.3: Food
    • 3.3.4: Medical Food
    • 3.3.5: Drugs
  • 3.4: Global Human Microbiome Market by Disease Type
    • 3.4.1: Infectious
    • 3.4.2: Metabolic/Endocrine
    • 3.4.3: Cancer
    • 3.4.4: Blood
    • 3.4.5: Neurological
  • 3.5: Global Human Microbiome Market by Research Technology
    • 3.5.1: Proteomics
    • 3.5.2: Metabolomics
    • 3.5.3: Genomics
  • 3.6: Global Human Microbiome Market by Application
    • 3.6.1: Therapeutics
    • 3.6.2: Diagnostics

4. Market Trends and Forecast Analysis by Region

  • 4.1: Global Human Microbiome Market by Region
  • 4.2: North American Human Microbiome Market
    • 4.2.1: Market by Product: Prebiotics, Probiotics, Food, Medical Food, and Drugs
    • 4.2.2: Market by Disease Type: Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological
    • 4.2.3: Market by Research Technology: Proteomics, Metabolomics, and Genomics
    • 4.2.4: Market by Application: Therapeutics and Diagnostics
    • 4.2.5: The US Human Microbiome Market
    • 4.2.6: Canadian Human Microbiome Market
    • 4.2.7: Mexican Human Microbiome Market
  • 4.3: European Human Microbiome Market
    • 4.3.1: Market by Product: Prebiotics, Probiotics, Food, Medical Food, and Drugs
    • 4.3.2: Market by Disease Type: Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological
    • 4.3.3: Market by Research Technology: Proteomics, Metabolomics, and Genomics
    • 4.3.4: Market by Application: Therapeutics and Diagnostics
    • 4.3.5: Human Microbiome Market of the United Kingdom
    • 4.3.6: German Human Microbiome Market
    • 4.3.7: French Human Microbiome Market
    • 4.3.8: Italian Human Microbiome Market
    • 4.3.9: Spanish Human Microbiome Market
  • 4.4: APAC Human Microbiome Market
    • 4.4.1: Market by Product: Prebiotics, Probiotics, Food, Medical Food, and Drugs
    • 4.4.2: Market by Disease Type: Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological
    • 4.4.3: Market by Research Technology: Proteomics, Metabolomics, and Genomics
    • 4.4.4: Market by Application: Therapeutics and Diagnostics
    • 4.4.5: Chinese Human Microbiome Market
    • 4.4.6: Japanese Human Microbiome Market
    • 4.4.7: Indian Human Microbiome Market
  • 4.5: ROW Human Microbiome Market
    • 4.5.1: Market by Product: Prebiotics, Probiotics, Food, Medical Food, and Drugs
    • 4.5.2: Market by Disease Type: Infectious, Metabolic/Endocrine, Cancer, Blood, and Neurological
    • 4.5.3: Market by Research Technology: Proteomics, Metabolomics, and Genomics
    • 4.5.4: Market by Application: Therapeutics and Diagnostics
    • 4.5.5: Brazilian Human Microbiome Market

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Market Share Analysis
  • 5.3: Geographical Reach
  • 5.4: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Human Microbiome Market by Product
    • 6.1.2: Growth Opportunities for the Global Human Microbiome Market by Disease Type
    • 6.1.3: Growth Opportunities for the Global Human Microbiome Market by Research Technology
    • 6.1.4: Growth Opportunities for the Global Human Microbiome Market by Application
    • 6.1.5: Growth Opportunities for the Global Human Microbiome Market by Region
  • 6.2: Emerging Trends in the Global Human Microbiome Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Human Microbiome Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Human Microbiome Market

7. Company Profiles of Leading Players

  • 7.1: Enterome
  • 7.2: Seres Therapeutics
  • 7.3: 4D Pharma
  • 7.4: DuPont
  • 7.5: Vedanta Biosciences
  • 7.6: Osel
  • 7.7: Yakult Hoshna
  • 7.8: Merck & Co
  • 7.9: Second Genome
  • 7.10: Metabiomics Corporation .